(Q53336903)

13 May 2018

title

CD133 expression in rectal cancer after preoperative chemoradiotherapy. (English)

1 reference

13 May 2018

0 references

6

Atsushi Ochiai

1 reference

13 May 2018

Genichiro Ishii

2

Genichiro Ishii

1 reference

13 May 2018

Motohiro Kojima

1

Motohiro Kojima

1 reference

13 May 2018

Q88891341

3

Naho Atsumi

1 reference

13 May 2018

Norio Saito

5

Norio Saito

1 reference

13 May 2018

Yuji Nishizawa

4

Yuji Nishizawa

1 reference

13 May 2018

publication date

19 December 2009

1 reference

13 May 2018

published in

Cancer Science

1 reference

13 May 2018

volume

101

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

906-912

1 reference

13 May 2018

Applying the principles of stem-cell biology to cancer

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

21 January 2018

Brain tumour stem cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Cancer stem cells and chemoradiation resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Cancer stem cell markers in common cancers - therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Phenotypic characterization of human colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Prostate cancer stem/progenitor cells: identification, characterization, and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Prominin: a story of cholesterol, plasma membrane protrusions and human pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Mechanism and biological significance of CD44 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Role of stem cells in cancer therapy and cancer stem cells: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Preoperative versus postoperative chemoradiotherapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Preoperative radiotherapy for rectal cancer: implications for surgeons, pathologists and radiologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Predicting response to cancer chemotherapy: the role of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Expression of standard CD44 in human colorectal carcinoma: association with prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2009.01478.X

10.1111/J.1349-7006.2009.01478.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018